Evidence map›Paper›PMID 34526966›Full record

SynthesisFrontiers in endocrinology2021

The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis.

Yongquan Gao, Xiaochen Liu, Yuan Gu, Deye Song, Muliang Ding, Lele Liao, Junjie Wang, Jiangdong Ni, Guangxu He

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Salvage of a Distal Ulnar Nonunion with Teriparatide Therapy.Journal of hand surgery global online · 2025
    Article
  7. Review
  8. Article
  9. Sentinel fracture: the necessity of improved post-fracture care.Wiener medizinische Wochenschrift (1946) · 2025
    Review
  10. Article
  11. Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Timing of osteoporosis therapies following fracture: the current status.Therapeutic advances in endocrinology and metabolism · 2022
    Review
  18. Bisphosphates for Osteoporosis: A Bibliometric Analysis of the Most Cited Articles.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yongquan GaoDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Xiaochen LiuDepartment Radiology, University of Toledo Medical Center, Toledo, OH, United States.
Yuan GuDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Deye SongDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Muliang DingDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Lele LiaoDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Junjie WangDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Jiangdong NiDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Guangxu HeDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CNUniversity of Toledo Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Osteoporosis is a common complication of acute fracture, which can lead to fracture delayed union or other complications and resulting in poor fracture healing. Bisphosphate is a common anti-osteoporosis drug, but its application in fracture patients is still controversial because of its inhibitory effect on bone resorption. Method: Studies were acquired from literature databases in accordance with established inclusion criteria. Standard mean difference (SMD) and 95% confidence intervals (Cls) were calculated to evaluate the effectiveness of the bisphosphonates treatment in fracture patients. Data analysis was conducted with the Review Manager 5.4.1 software. Results: A total of 16 studies involving 5022 patients obtained from selected databases were examined. As expected, bisphosphate had no significant effect on fracture healing time, but it could significantly increase BMD and prevent osteoporosis. Meanwhile, bisphosphate can inhibit both bone resorption and bone formation markers, resulting in low bone turnover state. Conclusion: This meta-analysis showed that bisphosphonate have no significant effect on fracture healing time but they do increase the changes in BMD and reduce bone synthesis and resorption markers. Early application of bisphosphonates after injury in the appropriate patient population should be considered.

Indexed as

Bone DensityBone Density Conservation AgentsBone RemodelingDiphosphonatesFracture HealingHumansOsteoporosisBone Density Conservation AgentsDiphosphonatesbisphosphonatesbone mass densitybone turnover markersfracture healingmeta-analysis

Identifiers

PMID34526966
PMCPMC8435630
OpenAlexW3197252013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.